SAN DIEGO and BUELACH, Switzerland, Sept. 24, 2018 /PRNewswire/ — Today, BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiroa and Xienceb drug-eluting stents (DES). The data shows statistically improved outcomes for patients treated with Orsiro across a range of clinical endpoints including 24-month target lesion […]